The expression profile across various cancer types and the matched normal tissues indicated that Pontin was significantly increased in a majority of cancers, including in brain GBMs and lower grade gliomas (LGGs; Supplementary Fig. S1). This evidence concerns the gene RUVBL1 and cancer.